












































United Nations A/C.3/58/L.60

 

General Assembly Distr.: Limited
17 November 2003

Original: English

03-61749 (E)    181103

*0361749*

Fifty-eighth session
Third Committee
Agenda item 117 (b)
Human rights questions: human rights questions, including
alternative approaches for improving the effective enjoyment
of human rights and fundamental freedoms

Angola, Argentina, Botswana, Brazil, Burkina Faso, Burundi, Cameroon,
Canada, Cape Verde, Chile, China, Colombia, Costa Rica, Côte d’Ivoire, Cuba,
Ghana, Dominican Republic, Ecuador, Guatemala, Mali, Mexico, Mozambique,
Panama, Paraguay, Peru, Saint Vincent and the Grenadines, Senegal, South
Africa, Thailand, Timor-Leste, Togo and Uruguay: draft resolution

Access to medication in the context of pandemics such as
HIV/AIDS, tuberculosis and malaria

The General Assembly,

Reaffirming the Universal Declaration of Human Rights1 and the International
Covenant on Economic, Social and Cultural Rights,2

Reaffirming also that the right of everyone to the enjoyment of the highest
attainable standard of physical and mental health is a human right,

Recalling Commission on Human Rights resolutions 2001/33 of 23 April
2001,3 2002/32 of 22 April 20024 and 2003/29 of 22 April 2003,5

Acknowledging that prevention and comprehensive care and support, including
treatment and access to medication for those infected and affected by pandemics
such as HIV/AIDS, tuberculosis and malaria, are inseparable elements of an
effective response and must be integrated into a comprehensive approach to respond
to such pandemics,

__________________
1 Resolution 217 A (III).
2 See resolution 2200 A (XXI), annex.
3 See Official Records of the Economic and Social Council, 2001, Supplement No. 3 (E/2001/23),

chap. II, sect. A.
4 Ibid., 2002, Supplement No. 3 (E/2002/23), chap. II, sect. A.
5 Ibid., 2003, Supplement No. 3 (E/2003/23), chap. II, sect. A.



2

A/C.3/58/L.60

Stressing the importance of fully implementing the Declaration of
Commitment on HIV/AIDS “Global Crisis — Global Action”6 and taking note of
the report of the Secretary-General on progress towards the implementation of the
Declaration,7

Welcoming the continuing political commitment demonstrated at the high-level
plenary meetings of the General Assembly devoted to the follow-up to the outcome
of its twenty-sixth special session and the implementation of the Declaration of
Commitment on HIV/AIDS, held on 22 September 2003,

Expressing its support for the work of the Global Fund to Fight AIDS,
Tuberculosis and Malaria and of other international bodies combating such
pandemics,

Bearing in mind World Health Assembly resolutions WHA 55.12 and WHA
55.14 of 18 May 2002 and WHA 56.30 of 28 May 2003,

Bearing also in mind the International Labour Organization Code of Practice
on HIV/AIDS and the World of Work, adopted by the Governing Body of the
International Labour Organization in June 2001,

Noting general comment No. 14 (2000) on the right to the highest attainable
standard of physical and mental health (article 12 of the International Covenant on
Economic, Social and Cultural Rights), adopted by the Committee on Economic,
Social and Cultural Rights at its twenty-second session, in May 2000,8

Noting general comment No. 3 (2003) on HIV/AIDS and the rights of the
child, adopted by the Committee on the Rights of the Child at its thirty-second
session, in January 2003,9

Alarmed that the HIV/AIDS pandemic claimed 3.1 million lives in 2002, that
about 42 million people were living with HIV by the end of 2002, and that 25
million children under the age of 15, including 20 million in Africa, are projected to
lose one or both parents owing to HIV/AIDS by 2010,

Fully aware that the failure to deliver antiretroviral treatment for HIV/AIDS to
the millions of people who need it causes a global health emergency,

Recalling its resolution 57/294 of 20 December 2002, entitled “2001-2010:
Decade to Roll Back Malaria in Developing Countries, particularly in Africa”,

Alarmed that, according to the global Roll Back Malaria partnership, malaria
annually causes more than 1 million deaths, around 90 per cent of which are in
Africa, that malaria is the leading cause of death in young children and that malaria
causes at least 300 million cases of acute illness each year,

Alarmed also that, according to the World Health Organization report of 2003
on global tuberculosis control,10 tuberculosis kills about 2 million people each year,
7 million to 8 million people around the world become sick with tuberculosis each

__________________
6 Resolution S-26/2, annex.
7 A/58/184.
8 Official Records of the Economic and Social Council, 2001, Supplement No. 2 (E/2001/22),

annex IV.
9 CRC/GC/2003/3.

10 WHO/CDS/TB/2003.316.



3

A/C.3/58/L.60

year and it is projected that between 2002 and 2020 36 million people will die of
tuberculosis if control is not further strengthened,

Acknowledging the significance of HIV/AIDS in the increase in tuberculosis
and other opportunistic diseases,

Welcoming the initiatives of the Secretary-General and relevant United Nations
agencies, States and civil society, including the private sector, to make drugs related
to HIV/AIDS, tuberculosis and malaria more accessible and affordable to infected
persons, especially in developing countries, and noting that much more could be
done in this regard,

Recalling the Declaration on the Agreement on Trade-Related Aspects of
Intellectual Property Rights and Public Health, adopted by the Fourth Ministerial
Conference of the World Trade Organization in Doha on 14 November 2001,11 and
welcoming the decision of the General Council of the World Trade Organization of
30 August 2003 on the implementation of paragraph 6 of the Doha Declaration,

Recognizing that the spread of HIV/AIDS can have a uniquely devastating
impact on all sectors and levels of society and stressing that the HIV/AIDS
pandemic, if unchecked, may pose a risk to stability and security, as stated in
Security Council resolution 1308 (2000) of 17 July 2000,

Emphasizing, in view of the increasing challenges presented by pandemics
such as HIV/AIDS, tuberculosis and malaria, the need for intensified efforts to
ensure universal respect for and observance of human rights and fundamental
freedoms for all, including by reducing vulnerability to pandemics such as
HIV/AIDS, tuberculosis and malaria and by preventing related discrimination and
stigma,

1. Recognizes that access to medication in the context of pandemics such as
HIV/AIDS, tuberculosis and malaria is one fundamental element for achieving
progressively the full realization of the right of everyone to the enjoyment of the
highest attainable standard of physical and mental health;

2. Welcomes the commitment of the World Health Organization and the
Joint United Nations Programme on HIV/AIDS to work with the international
community to support developing countries in achieving the global target of
providing antiretroviral medicines to 3 million people infected with HIV/AIDS by
the end of 2005, the “3 by 5” target;

3. Takes note with interest of the interim report of the Special Rapporteur of
the Commission on Human Rights on the right of everyone to the enjoyment of the
highest attainable standard of physical and mental health;12

4. Calls upon States to develop and implement national strategies, in
accordance with applicable international law, including international agreements
acceded to, in order progressively to realize access for all to prevention-related
goods, services and information as well as access to comprehensive treatment, care
and support for all individuals infected and affected by pandemics such as
HIV/AIDS, tuberculosis and malaria;

__________________
11 WT/MIN(01)/DEC/2. Available on the Internet at http://docsonline.wto.org.
12 A/58/427.



4

A/C.3/58/L.60

5. Also calls upon States to establish or strengthen national health and
social infrastructures and health-care systems, with the assistance of the
international community as necessary, for the effective delivery of prevention,
treatment, care and support to respond to pandemics such as HIV/AIDS,
tuberculosis and malaria;

6. Further calls upon States to pursue policies, in accordance with
applicable international law, including international agreements acceded to, which
would promote:

(a) The availability in sufficient quantities of pharmaceutical products and
medical technologies used to treat pandemics such as HIV/AIDS, tuberculosis and
malaria or the most common opportunistic infections that accompany them;

(b) The accessibility and affordability for all without discrimination,
including the most vulnerable or socially disadvantaged groups of the population, of
pharmaceutical products or medical technologies used to treat pandemics such as
HIV/AIDS, tuberculosis, malaria or the most common opportunistic infections that
accompany them;

(c) The assurance that pharmaceutical products or medical technologies used
to treat pandemics such as HIV/AIDS, tuberculosis, malaria or the most common
opportunistic infections that accompany them, irrespective of their sources and
countries of origin, are scientifically and medically appropriate and of good quality;

7. Calls upon States, at the national level, on a non-discriminatory basis, in
accordance with applicable international law, including international agreements
acceded to:

(a) To refrain from taking measures that would deny or limit equal access for
all persons to preventive, curative or palliative pharmaceutical products or medical
technologies used to treat pandemics such as HIV/AIDS, tuberculosis, malaria or the
most common opportunistic infections that accompany them;

(b) To adopt and implement legislation or other measures, in accordance with
applicable international law, including international agreements acceded to, to
safeguard access to such preventive, curative or palliative pharmaceutical products
or medical technologies from any limitations by third parties;

(c) To adopt all appropriate positive measures, to the maximum of the
resources allocated for this purpose, to promote effective access to such preventive,
curative or palliative pharmaceutical products or medical technologies;

8. Also calls upon States, in furtherance of the Declaration of Commitment
on HIV/AIDS,6 to address factors affecting the provision of drugs related to the
treatment of pandemics such as HIV/AIDS and the most common opportunistic
infections that accompany them, as well as to develop integrated strategies to
strengthen health-care systems, including voluntary counselling and testing,
laboratory capacities and the training of health-care providers and technicians, in
order to provide treatment and monitor the use of medications, diagnostics and
related technologies;

9. Further calls upon States to take all appropriate measures, nationally and
through cooperation, to promote research and development of new and more
effective preventive, curative or palliative pharmaceutical products and diagnostic



5

A/C.3/58/L.60

tools, in accordance with applicable international law, including international
agreements acceded to;

10. Calls upon States, at the international level, to take steps, individually
and/or through international cooperation, in accordance with applicable international
law, including international agreements acceded to, such as:

(a) To facilitate, wherever possible, access in other countries to essential
preventive, curative or palliative pharmaceutical products or medical technologies
used to treat pandemics such as HIV/AIDS, tuberculosis and malaria or the most
common opportunistic infections that accompany them, as well as to extend the
necessary cooperation, wherever possible, especially in times of emergency;

(b) To ensure that their actions as members of international organizations
take due account of the right of everyone to the enjoyment of the highest attainable
standard of physical and mental health and that the application of international
agreements is supportive of public health policies which promote broad access to
safe, effective and affordable preventive, curative or palliative pharmaceutical
products and medical technologies;

11. Welcomes the financial contributions made to date to the Global Fund to
Fight AIDS, Tuberculosis and Malaria, urges that further contributions be made to
sustain the Fund, and calls upon all States to encourage the private sector to
contribute to the Fund as a matter of urgency;

12. Calls upon the Joint United Nations Programme on HIV/AIDS to
mobilize further resources to combat the HIV/AIDS pandemic and upon all
Governments to take measures to ensure that the necessary resources are made
available to the Joint United Nations Programme on HIV/AIDS, in line with the
Declaration of Commitment on HIV/AIDS;

13. Also calls upon States to ensure that those at risk of contracting malaria,
in particular pregnant women and children under five years of age, benefit from the
most suitable combination of personal and community protective measures, such as
insecticide treated bed nets and other interventions that are accessible and
affordable, to prevent infection and suffering;

14. Further calls upon States to provide the necessary support for the World
Health Organization Roll Back Malaria and Stop Tuberculosis partnerships in
ongoing measures to combat malaria and tuberculosis;

15. Calls upon the international community, the developed countries in
particular, to continue to assist the developing countries in the fight against
pandemics such as HIV/AIDS, tuberculosis and malaria through financial and
technical support, as well as through the training of personnel;

16. Invites the Committee on Economic, Social and Cultural Rights to give
attention to the issue of access to medication in the context of pandemics such as
HIV/AIDS, tuberculosis and malaria and invites States to include appropriate
information thereon in the reports they submit to the Committee.


